Compare Cipher Mining Inc (CIFR) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipher Mining Inc vs BIO-TECHNE Corp — how do they compare? Cipher Mining Inc trades at $17.76 (market cap $7.14B), while BIO-TECHNE Corp trades at $72.25 (market cap $11.24B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Cipher Mining Inc pays none. Which is the better fit depends on your goals.
| CIFR | TECH | |
|---|---|---|
Market Cap | $7.14B | $11.24B |
Sector | Basic Materials | Health |
52-Week High | $29.18 | $72.29 |
52-Week Low | $4.72 | $43.31 |
Enterprise Value | $11.90B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CIFR trades at $18.35, up 12.37% in the last 24 hours, but remains in a bearish technical trend. The company reported a Q2 2026 loss of $0.65 per share, missing estimates, with revenue declining and net losses widening. Despite negative profitability metrics, analyst consensus is unanimously bullish with a $31.78 price target, citing progress in its transition to AI data center operations and accelerated project deliveries.
The outlook hinges on successful execution of its AI infrastructure pivot, offering significant upside if targets are met, but high execution risks and persistent losses pose substantial threats to shareholder value. Investors face volatility amid the business model transition.
TECH trades at $72.25, up 0.18% today, with a bullish technical signal and moving averages supporting an uptrend. The company reported Q4 2026 earnings of $0.52 per share, meeting estimates, while revenue beat expectations on strong research and diagnostics demand. Financials show a gross profit margin of 64.96%, but net income margin has declined to 9.05% in 2025 from 25.09% in 2023. Analyst consensus is evenly split between Buy and Hold, with a price target of $71.67.
The stock presents a mixed outlook: strong cash flow and institutional interest contrast with high valuation multiples and margin compression. Key risks include competitive pressures and execution challenges in maintaining profitability. Upside potential hinges on sustained revenue growth and margin recovery, but investors should weigh the elevated P/E of 103 against earnings stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipher Mining Inc
Cipher Mining is an industrial-scale technology company focused on Bitcoin mining infrastructure. It develops and operates data centers in the US designed to strengthen the Bitcoin network and support decentralized finance.
Read more on CIFR →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
